Congress Demands Answers on Data Privacy Ahead of 23andMe Sale

In a bold move, members of Congress have demanded answers on data privacy concerns ahead of the sale of popular genetic testing company, 23andMe.

There is growing concern among lawmakers about how the sensitive genetic information of millions of customers will be protected in the event of a sale.

Several privacy advocates have warned that the sale could potentially compromise the privacy and security of genetic data collected by 23andMe.

Congress is seeking assurances from 23andMe and the potential buyers that they will uphold the highest standards of data privacy and protection.

The company has reassured customers that their data will remain secure and protected, but many are still skeptical of the sale.

The sale of 23andMe comes at a time when data privacy issues are at the forefront of public debate, with many calling for more stringent regulations to protect consumer data.

Congress is under pressure to ensure that the sale of 23andMe does not compromise the privacy and security of genetic information collected by the company.

Many are calling for increased transparency and accountability from both 23andMe and the potential buyers to ensure that customer data is not misused or compromised in any way.

The outcome of this sale and the measures taken to protect customer data could have far-reaching implications for the future of data privacy and protection in the digital age.

Only time will tell if Congress’s demands for answers on data privacy concerns ahead of the 23andMe sale will lead to meaningful change and increased protections for consumer data.